PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMBCL)
Clinical trials for PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMBCL) explained in plain language.
Never miss a new study
Get alerted when new PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMBCL) trials appear
Sign up with your email to follow new studies for PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMBCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cancer drug shows promise in Hard-to-Treat lymphoma patients
Disease control CompletedThis study tested the drug pembrolizumab (Keytruda) given every 6 weeks in 66 adults whose Hodgkin's lymphoma or PMBCL had come back or not responded to prior treatment. The main goal was to see how many participants had their tumors shrink or disappear. Results showed that some …
Matched conditions: PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMBCL)
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 26, 2026 09:06 UTC
-
Italian study reveals Real-World PMBCL outcomes over 13 years
Knowledge-focused CompletedThis study looked back at the medical records of 633 adults with a rare type of lymphoma (PMBCL) treated between 2007 and 2019. The goal was to see how well different treatments worked, how often the disease came back, and what side effects patients experienced. No new treatments…
Matched conditions: PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMBCL)
Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Knowledge-focused
Last updated May 26, 2026 09:00 UTC